ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1867

Body Composition in Myositis Patients Is Negatively Changed Compared to Healthy Controls and the Changes Are Associated with Disease Activity and Duration, Skeletal Muscle Involvement and Physical Activity and Nutritional Status

Sabina Oreska1, Maja Spiritovic 2, Petr Cesak 3, Ondrej Marecek 3, Hana Storkanova 4, Barbora Hermankova 3, Katerina Kubinova 5, Martin Klein 4, Lucia Vernerová 4, Olga Ruzickova 4, Karel Pavelka 1, Ladislav Senolt 1, Herman Mann 1, Jiří Vencovský 1 and Michal Tomcik 1, 1Institute of Rheumatology, Department of Rheumatology, 1st Faculty of Medicine, Prague, Czech Republic, Prague 2, Czech Republic, 2Faculty of Physical Education and Sport, Department of Physiotherapy, Charles University, Prague, Czech Republic, Prague 2, Hlavni mesto Praha, Czech Republic, 3Faculty of Physical Education and Sport, Department of Physiotherapy, Charles University, Prague, Czech Republic, Prague, Czech Republic, 4Institute of Rheumatology, Department of Rheumatology, 1st Faculty of Medicine, Prague, Czech Republic, Prague, Czech Republic, 5Institute of Rheumatology, Department of Rheumatology, 1st Faculty of Medicine, Prague, Czech Republic, Prague 2

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: body composition, inflammatory cytokines, inflammatory myositis, nutrition and lipids

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 11, 2019

Title: 4M113: Muscle Biology, Myositis & Myopathies I (1866–1871)

Session Type: ACR Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: Skeletal muscle, pulmonary and articular involvement in idiopathic inflammatory myopathies (IIM) limit the mobility/self-sufficiency of patients, and can have a negative impact on body composition. The aim of this study was to assess body composition and physical activity of IIM patients and healthy controls (HC) and the association with chosen inflammatory cytokines/chemokines and laboratory markers of nutrition and lipid metabolism.

Methods: 54 patients with IIM (45 females; mean age 57.7; disease duration 5.8 years; polymyositis (PM, 22) / dermatomyositis (DM, 25) / necrotizing myopathy (IMNM, 7)) and 54 age-/sex-matched HC (45 females, mean age 57.7) without rheumatic/tumor diseases were included. PM/DM patients fulfilled Bohan/Peter criteria for PM/DM. We assessed body composition (densitometry: iDXA Lunar, bioelectric impedance: BIA2000-M), physical activity (Human Activity Profile (HAP) questionnaire, serum levels of 27 cytokines/chemokines (commercial multiplex ELISA kit, Bio-Rad Laboratories) and serum levels of chosen parameters of nutrition and lipidogram. Disease activity (MITAX and MYOACT activity score) and muscle involvement (manual muscle test, MMT-8, and functional index 2, FI2) were evaluated. Data are presented as mean±SD.

Results: Compared to HC, patients with IIM had a trend towards significantly increased body fat % (BF%) as assessed by iDXA, but significantly decreased lean body mass (LBM) as assessed both by iDXA and BIA, and increased extracellular mass/body cell mass (ECM/BCM) ratio reflecting worse muscle predispositions for physical exercise, aerobic fitness/performance, and deteriorated nutritional status. Compared to HC, IIM patients had significantly lower bone mineral density (BMD) (Table 1). Disease duration negatively correlated with BMD and LBM-BIA. Disease activity assessed by both MITAX and MYOACT positively correlated with LBM (by BIA and iDXA), similarly as with basal metabolic rate (BMR) and fat free mass (FFM). CRP was positively associated with BF% (by iDXA and BIA). Higher BF%-iDXA was associated with worse physical endurance (Function Index-2, FI-2) and worse ability to perform physical activity (HAP). MMT-8 score negatively correlated with ECM/BCM ratio (Table 2). Serum levels of several inflammatory cytokines/chemokines (Table 3) and markers of nutrition and lipid metabolism were associated with alterations of body composition (Table 4 and 5).

Conclusion: Compared to healthy age-/sex-matched individuals we found significant negative changes in body composition of our IIM patients, which are associated with their disease activity and duration, inflammatory status, skeletal muscle involvement, and physical activity. These data could reflect their impaired nutritional status and predispositions for physical exercise, aerobic fitness and performance. Serum levels of certain inflammatory cytokines/chemokines and markers of nutrition and lipid metabolism were associated with alterations of body composition in IIM patients.

Acknowledgement: Supported by AZV NV18-01-00161A, MHCR 023728 and GAUK 312218

Table 1: Body composition in IIM and HC.

Table 2: Correlation of body composition parameters and clinical features of IIM: disease duration and activity, inflammation, muscle involvement, physical ability.

Table 3: Correlation of body composition parameters and serum levels of inflammatory
cytokines/chemokines -pg/mL-;
Table 4: Correlation of body composition parameters and serum parameters of nutrition.
Table 5: Correlation of body composition parameters and serum parameters of lipid metabolism.


Disclosure: S. Oreska, None; M. Spiritovic, None; P. Cesak, None; O. Marecek, None; H. Storkanova, None; B. Hermankova, None; K. Kubinova, Ministry of Health, Czech Republic, project 00023728, 2; M. Klein, None; L. Vernerová, None; O. Ruzickova, None; K. Pavelka, AbbVie, 8, Abbvie, 5, 8, Amgen, 5, 8, BMS, 8, Egis, 5, 8, Lilly, 5, 8, MSD, 8, Novartis, 5, 8, Pfizer, 5, 8, Roche, 5, 8, UCB, 8; L. Senolt, None; H. Mann, None; J. Vencovský, projeMinistry of Health, Czech Republic, project 00023728, 2; M. Tomcik, None.

To cite this abstract in AMA style:

Oreska S, Spiritovic M, Cesak P, Marecek O, Storkanova H, Hermankova B, Kubinova K, Klein M, Vernerová L, Ruzickova O, Pavelka K, Senolt L, Mann H, Vencovský J, Tomcik M. Body Composition in Myositis Patients Is Negatively Changed Compared to Healthy Controls and the Changes Are Associated with Disease Activity and Duration, Skeletal Muscle Involvement and Physical Activity and Nutritional Status [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/body-composition-in-myositis-patients-is-negatively-changed-compared-to-healthy-controls-and-the-changes-are-associated-with-disease-activity-and-duration-skeletal-muscle-involvement-and-physical-act/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/body-composition-in-myositis-patients-is-negatively-changed-compared-to-healthy-controls-and-the-changes-are-associated-with-disease-activity-and-duration-skeletal-muscle-involvement-and-physical-act/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology